OSTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OS Therapies Inc (OSTX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, insider selling, no positive news catalysts, and a high probability of negative price movement in the short and medium term. Additionally, there are no strong trading signals or analyst support to justify a buy decision.
The MACD is positive and expanding, indicating a bullish momentum. However, the RSI is at 74.56, suggesting the stock is approaching overbought territory. Moving averages are converging, showing no clear trend. Key resistance levels are at 1.49 and 1.57, while support levels are at 1.36 and 1.23. The stock is currently trading at 1.52 in pre-market, close to resistance levels, which limits upside potential.
NULL identified. There is no recent news, no positive financial growth, and no significant trading trends supporting a bullish case.
Insiders are selling, with a 100.96% increase in selling activity over the last month. The stock has a 60% probability of declining by -1.27% in the next day, -2.18% in the next week, and -17.79% in the next month. Financial performance is weak, with no revenue growth and negative net income.
In Q3 2025, the company reported no revenue growth (0% YoY) and a negative net income of -$6,879,530, despite a 139.27% YoY improvement. EPS improved to -0.22 (up 57.14% YoY), but it remains negative. Gross margin is 0%, indicating no profitability.
No analyst ratings or price target changes are available for OSTX.
